Anterogen Co (XKRX:065660) Interest Expense : ₩-1,345 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Anterogen Co's interest expense for the three months ended in Mar. 2024 was ₩ -260 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,345 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Anterogen Co's Operating Income for the three months ended in Mar. 2024 was ₩ -951 Mil. Anterogen Co's Interest Expense for the three months ended in Mar. 2024 was ₩ -260 Mil. Anterogen Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Anterogen Co Interest Expense Historical Data

The historical data trend for Anterogen Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Interest Expense Chart

Anterogen Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1,092.99

-315.43

-1,241.31

-1,694.51

-1,526.04

Anterogen Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-440.62	-415.99	-327.35	-342.07	-259.60

Anterogen Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,345 Mil.

Anterogen Co (XKRX:065660) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Anterogen Co's Interest Expense for the three months ended in Mar. 2024 was ₩-260 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩-951 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩0 Mil.

Anterogen Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Anterogen Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Anterogen Co (XKRX:065660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines